Federal Rule Provides Flexibility in Dispensing Buprenorphine for Opioid Addiction Treatment in OTPs

The Substance Abuse Mental Health Services Administration (SAMHSA) issued a Federal rule to allow patients being treated through an opioid treatment program (OTP) to receive take-home supplies of buprenorphine from an OTP in a more flexible manner. Buprenorphine is a medication used in opioid addiction treatment. The regulation takes effect on January 7, 2013.

Under the rule change, OTPs will be permitted to dispense buprenorphine to eligible patients without having to adhere to previous length of time in treatment requirements. Currently, OTPs require a person to be in treatment a certain amount of time before being given a multiple days’ supply of medicine to take home.

The change in the rule will not affect requirements for dispensing methadone. SAMHSA based the change in the restrictions for dispensing buprenorphine on several factors. These include differences in the abuse potential between methadone and buprenorphine, as well as the actual abuse and mortality rates (buprenorphine is lower in each instance).

For more information on the rule, go to: http://www.ofr.gov/OFRUpload/OFRData/2012-29417_PI.pdf

The Federal Register notice can be accessed at: https://www.federalregister.gov/articles/2012/12/06/2012-29417/opioid-drugs-in-maintenance-and-detoxification-treatment-of-opiate-addiction-proposed-modification

Source: The Substance Abuse Mental Health Services Administration – December 6, 2012

New Issue of SAMHSA News Features Articles on Health Information Technology

The Winter/Spring 2012 issue of the Substance Abuse Mental Health Services Administration (SAMHSA) News feature articles on Health Information Technology: What It Means For You and SAMHSA Enhances Health Information Technology Efforts.

SAMHSA Administrator Pamela S. Hyde, J.D. notes “the full impact of a health system that opens the door to rapid, efficient, innovative care can only be realized when behavioral health providers are able to access and embrace health information technology (HIT) and electronic health record (HER) systems to coordinate care with primary care providers.”

http://www.samhsa.gov/samhsaNewsletter/Volume_20_Number_1/Winter2012-volume-20-number-1.pdf

Source:  Substance Abuse Mental Health Services Administration – May 2012    

Why Xanax is the Most Popular Anti-Anxiety Drug in America


So reliably relaxing are the effects of benzodiazepines that ­SAMHSA’s director of substance-abuse treatment, H. Westley Clark, says they’ve gained a reputation as “alcohol in a pill.” And their consumption can be equally informal. Just as friends pour wine for friends in times of crisis, so too do doctors, moved by the angst of their patients, “have sympathy and prescribe more,” says Clark. There are a lot more benzos circulating these days, and a lot more sharing.

http://nymag.com/news/features/xanax-2012-3/

Source: New York Magazine – March 18, 2012

SAMHSA News Winter 2012 Now Available Online

The Winter edition of the Substance Abuse Mental Health Services Administration is now available online at: http://www.samhsa.gov/samhsaNewsletter/Volume_20_Number_1/Winter2012-volume-20-number-1.pdf

Articles in this issue include:

¨       Health Information Technology—What It Means for You

¨       SAMHSA Enhances Health IT Efforts

¨       Behavioral Health IT Resources

¨       View From the Administrator: Embracing Health Information Technology

¨       Using Social Media To Save Lives

¨       Study Finds One in Five American Adults With Mental Illness

¨       National Survey on Drug Use and Health shows 45.9 million adults across the United States experienced mental illness in the past year.

¨       SAMHSA’s Budget Affirms Commitment to Behavioral Health

¨       Celebrating 20 Years of Behavioral Health Advances

¨       SAMHSA Releases Two New Resources

Source: Substance Abuse Mental Health Services Administration – March 29, 2012

SAMHSA Announces Working Definition and Guiding Principles of Recovery

A new working definition of recovery from mental disorders and substance use disorders was announced Dec 22 by the Substance Abuse and Mental Health Services Administration (SAMHSA). The definition is the product of a year-long effort by SAMHSA and a wide range of partners in the behavioral health care community and other fields to develop a working definition of recovery that captures the essential, common experiences of those recovering from mental disorders and substance use disorders, along with major guiding principles that support the recovery definition. SAMHSA led this effort as part of its Recovery Support Strategic Initiative.

The new working definition of Recovery for Mental Disorders and Substance Use Disorders is as follows:

A process of change through which individuals improve their health and wellness, live a self-directed life, and strive to reach their full potential.

Through the Recovery Support Strategic Initiative, SAMHSA has delineated four major dimensions that support a life in recovery:

  • Health: overcoming or managing one’s disease(s) as well as living in a physically and emotionally healthy way;
  • Home: a stable and safe place to live;
  • Purpose: meaningful daily activities, such as a job, school, volunteerism, family caretaking, or creative endeavors, and the independence, income and resources to participate in society; and
  • Community: relationships and social networks that provide support, friendship, love, and hope.

The press release can be accessed at: http://www.samhsa.gov/newsroom/advisories/1112223420.aspx

For more on the Guiding Principles of Recovery go to: http://blog.samhsa.gov/2011/12/22/samhsa%E2%80%99s-definition-and-guiding-principles-of-recovery-%E2%80%93-answering-the-call-for-feedback/

Source: The Substance Abuse and Mental Health Services Administration – December 22, 2011

New Report: Illicit Drug-Related Emergency Department Visits in Metropolitan Areas of the United States: 2009

hospital signMajor metropolitan areas show significant variation in the rates of emergency department (ED) visits involving illicit drugs. In terms of overall illicit drug-related emergency room visits, Boston has the highest rate (571 per 100,000 population), followed by New York City (555 per 100,000 population), Chicago (507 per 100,000 population), and Detroit (462 per 100,000 population). By comparison the national average was 317 per 100,000 population.

This new report published by the Substance Abuse and Mental Health Services Administration (SAMHSA) was drawn from the agency’s Drug Abuse Warning Network (DAWN), a public health surveillance system that monitors drug-related emergency department visits throughout the nation. This information was collected from eleven metropolitan areas including Boston, Chicago, Denver, Detroit, Miami (Dade County and Fort Lauderdale Division), Minneapolis, New York (Five Boroughs Division), Phoenix, San Francisco, and Seattle.

“When friends, family members and health professionals miss the signs and symptoms of substance abuse the results can be devastating,” said SAMHSA Administrator Pamela S. Hyde. “One consequence is the costly and inefficient use of emergency rooms as a first step to treatment. Substance abuse prevention and early intervention can keep people off drugs in the first place and clear the path to healthier lifestyles.”

The emergency department findings were similar to the overall trend regarding visits related specifically to heroin use. Again Boston had the highest rate (251 per 100,000 population, followed by Chicago (216 per 100,000 population), New York City (153 per 100,000 population), Detroit (150 per 100,000 population) and Seattle (118 per 100,000 population). The national average was 69 per 100,000.

The report can be accessed at: http://www.samhsa.gov/data/2k11/WEB_DAWN_023/DAWN_023_IllicitDrugEDVisits_plain.pdf

Source: Substance Abuse and Mental Health Services Administration – December 15, 2011

SAMHSA Announces its Inaugural Science and Service Awards for Opioid Treatment Programs and Office-Based Opioid Treatment Providers

The Substance Abuse and Mental Health Services Administration (SAMHSA) is seeking applications from qualified opioid treatment programs (OTPs) and office-based opioid treatment providers (OBOT) for the 2012 Science and Service Awards Program. This national awards program promotes excellence in the treatment of opioid addiction by honoring OTPs and OBOT providers using pharmacotherapy and other innovative approaches to enhance patient outcomes.

The OTP awards will be announced at the 2012 national conference of the American Association for the Treatment of Opioid Dependence (AATOD), and the OBOT awards will be announced at the 43rd Annual Medical Scientific Conference of the American Society for Addiction Medicine (ASAM). A panel of experts will review the award applications and select five awardees from two categories: OTPs and OBOTs.

All winners will receive a Science and Service award and will be prominently highlighted on SAMHSA’s web site.

Both SAMHSA certified and accredited OTPs and physicians  who have submitted a notification of intent to SAMHSA and who have been assigned a unique identification number (x-number) by the Drug Enforcement Administration (DEA) under the Drug Addiction Treatment Act of 2000 (DATA 2000) are eligible.

The application form is available at: http://www.samhsa.gov/Scienceandservice/index.aspx

The deadline for submitting a completed application, electronically or hard copy is Friday, January 13, 2012, at 5:00 pm, Eastern Standard Time. 

Source: Substance Abuse and Mental Health Services Administration – December 8, 2011


Source:
Substance Abuse and Mental Health Services Administration – December 8, 2011

Site last updated May 13, 2013 @ 4:22 pm